A detailed history of G&S Capital LLC transactions in Johnson & Johnson stock. As of the latest transaction made, G&S Capital LLC holds 5,027 shares of JNJ stock, worth $736,003. This represents 0.36% of its overall portfolio holdings.

Number of Shares
5,027
Previous 4,936 1.84%
Holding current value
$736,003
Previous $721,000 12.9%
% of portfolio
0.36%
Previous 0.31%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$145.48 - $167.38 $13,238 - $15,231
91 Added 1.84%
5,027 $814,000
Q2 2024

Jul 30, 2024

SELL
$144.38 - $157.78 $16,314 - $17,829
-113 Reduced 2.24%
4,936 $721,000
Q1 2024

Apr 15, 2024

SELL
$155.22 - $162.74 $2.28 Million - $2.39 Million
-14,715 Reduced 74.45%
5,049 $798,000
Q4 2023

Jan 26, 2024

SELL
$145.6 - $158.88 $42,078 - $45,916
-289 Reduced 1.44%
19,764 $3.1 Million
Q3 2023

Oct 12, 2023

SELL
$155.75 - $174.48 $23,051 - $25,823
-148 Reduced 0.73%
20,053 $3.12 Million
Q2 2023

Jul 26, 2023

BUY
$154.35 - $166.11 $1.1 Million - $1.19 Million
7,150 Added 54.79%
20,201 $3.34 Million
Q1 2023

Apr 20, 2023

BUY
$151.05 - $180.26 $1.25 Million - $1.49 Million
8,254 Added 172.07%
13,051 $2.02 Million
Q4 2022

Jan 20, 2023

BUY
$160.2 - $179.79 $10,733 - $12,045
67 Added 1.42%
4,797 $0
Q3 2022

Oct 21, 2022

BUY
$161.33 - $179.52 $11,131 - $12,386
69 Added 1.48%
4,730 $773,000
Q2 2022

Jul 21, 2022

BUY
$168.19 - $186.01 $672 - $744
4 Added 0.09%
4,661 $827,000
Q1 2022

Apr 15, 2022

SELL
$158.14 - $179.59 $29,888 - $33,942
-189 Reduced 3.9%
4,657 $825,000
Q4 2021

Jan 20, 2022

SELL
$155.93 - $173.01 $13,098 - $14,532
-84 Reduced 1.7%
4,846 $829,000
Q3 2021

Oct 19, 2021

BUY
$161.5 - $179.47 $15,988 - $17,767
99 Added 2.05%
4,930 $796,000
Q2 2021

Jul 22, 2021

BUY
$159.48 - $171.07 $478 - $513
3 Added 0.06%
4,831 $796,000
Q1 2021

Apr 15, 2021

SELL
$153.07 - $170.48 $10,561 - $11,763
-69 Reduced 1.41%
4,828 $793,000
Q4 2020

Jan 21, 2021

SELL
$137.11 - $157.38 $3.03 Million - $3.48 Million
-22,119 Reduced 81.87%
4,897 $771,000
Q3 2020

Oct 21, 2020

BUY
$140.38 - $153.83 $1.57 Million - $1.72 Million
11,181 Added 70.61%
27,016 $4.02 Million
Q2 2020

Jul 24, 2020

SELL
$128.81 - $155.51 $1.74 Million - $2.11 Million
-13,544 Reduced 46.1%
15,835 $2.23 Million
Q1 2020

Apr 23, 2020

BUY
$111.14 - $153.99 $1.78 Million - $2.47 Million
16,050 Added 120.41%
29,379 $3.85 Million
Q4 2019

Jan 21, 2020

BUY
$127.5 - $146.44 $1.1 Million - $1.27 Million
8,661 Added 185.54%
13,329 $1.94 Million
Q3 2019

Oct 17, 2019

BUY
$126.95 - $142.14 $10,663 - $11,939
84 Added 1.83%
4,668 $604,000
Q2 2019

Jul 19, 2019

SELL
$131.15 - $144.24 $99,149 - $109,045
-756 Reduced 14.16%
4,584 $638,000
Q1 2019

Apr 22, 2019

SELL
$125.72 - $139.79 $14,583 - $16,215
-116 Reduced 2.13%
5,340 $747,000
Q4 2018

Jan 15, 2019

SELL
$122.84 - $147.84 $11,546 - $13,896
-94 Reduced 1.69%
5,456 $704,000
Q3 2018

Oct 30, 2018

BUY
$121.58 - $142.88 $10,455 - $12,287
86 Added 1.57%
5,550 $767,000
Q2 2018

Aug 01, 2018

BUY
$119.4 - $131.76 $119 - $131
1 Added 0.02%
5,464 $663,000
Q1 2018

Apr 25, 2018

BUY
$125.1 - $148.14 $4,253 - $5,036
34 Added 0.63%
5,463 $700,000
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $712,393 - $779,712
5,429
5,429 $759,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $383B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track G&S Capital LLC Portfolio

Follow G&S Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of G&S Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on G&S Capital LLC with notifications on news.